Effects of risedronate on osteoarthritis of the knee (Q33670485)

28 July 2017

5 references

13 March 2019

17 June 2019

2 October 2019

12 November 2019

25 August 2022

Effects of risedronate on osteoarthritis of the knee (English)

1 reference

organic compound, having C-P covalent bound

28 July 2017

5 references

13 March 2019

17 June 2019

2 October 2019

12 November 2019

25 August 2022

1 reference

2 October 2019

1 reference

12 November 2019

1 reference

Jun Iwamoto

1

1 reference

28 July 2017

Tsuyoshi Takeda

series ordinal

2

1 reference

28 July 2017

Yoshihiro Sato

series ordinal

3

1 reference

28 July 2017

Hideo Matsumoto

series ordinal

4

1 reference

28 July 2017

language of work or name

1 reference

12 February 2010

1 reference

28 July 2017

1 March 2010

5 references

13 March 2019

17 June 2019

2 October 2019

12 November 2019

25 August 2022

Yonsei Medical Journal

6 references

28 July 2017

13 March 2019

17 June 2019

2 October 2019

12 November 2019

25 August 2022

51

1 reference

28 July 2017

2

1 reference

28 July 2017

164-170

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

28 July 2017

5 references

13 March 2019

17 June 2019

2 October 2019

12 November 2019

on focus list of Wikimedia project

25 August 2022

ScienceSource

0 references

cites work

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Tibial plateau size is related to grade of joint space narrowing and osteophytes in healthy women and in women with osteoarthritis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Bisphosphonates: potential therapeutic agents for disease modification in osteoarthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Epidemiology of risk factors for osteoarthritis: systemic factors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Bisphosphonates for osteoarthritis prevention: "Holy Grail" or not?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

The effect of alendronate on progression of spinal osteophytes and disc-space narrowing

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Effects of strontium ranelate on spinal osteoarthritis progression.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Quantitative microfocal radiographic assessment of osteoarthritis of the knee from weight bearing tunnel and semiflexed standing views.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824859

Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study

30 October 2018

1 reference

12 December 2020

Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females

1 reference

12 December 2020

Spontaneous cartilage degeneration in guinea pigs

1 reference

12 December 2020

Calculated stress-shielding in the distal femur after total knee replacement corresponds to the reported location of bone loss

1 reference

12 December 2020

Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation

1 reference

12 December 2020

Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process

1 reference

12 December 2020

10.3349/YMJ.2010.51.2.164

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference